Oddershede JK, Meklenborg IK, Bastholt L, Guldbrandt LM, Schmidt H, Friis RB. Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility. AO [Internet]. 2025 Apr. 13 [cited 2026 May 28];64:507-15. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/42567